Mitophagy Mediates the Beige to White Transition of Human Primary Subcutaneous Adipocytes Ex Vivo.

beige adipocytes mitophagy obesity parkin thermogenesis uncoupling protein 1

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 16 02 2022
revised: 11 03 2022
accepted: 14 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 27 3 2022
Statut: epublish

Résumé

Brown and beige adipocytes have multilocular lipid droplets, express uncoupling protein (UCP) 1, and promote energy expenditure. In rodents, when the stimulus of browning subsides, parkin-dependent mitophagy is activated and dormant beige adipocytes persist. In humans, however, the molecular events during the beige to white transition have not been studied in detail. In this study, human primary subcutaneous abdominal preadipocytes were differentiated to beige for 14 days, then either the beige culture conditions were applied for an additional 14 days or it was replaced by a white medium. Control white adipocytes were differentiated by their specific cocktail for 28 days. Peroxisome proliferator-activated receptor γ-driven beige differentiation resulted in increased mitochondrial biogenesis, UCP1 expression, fragmentation, and respiration as compared to white. Morphology, UCP1 content, mitochondrial fragmentation, and basal respiration of the adipocytes that underwent transition, along with the induction of mitophagy, were similar to control white adipocytes. However, white converted beige adipocytes had a stronger responsiveness to dibutyril-cAMP, which mimics adrenergic stimulus, than the control white ones. Gene expression patterns showed that the removal of mitochondria in transitioning adipocytes may involve both parkin-dependent and -independent pathways. Preventing the entry of beige adipocytes into white transition can be a feasible way to maintain elevated thermogenesis and energy expenditure.

Identifiants

pubmed: 35337160
pii: ph15030363
doi: 10.3390/ph15030363
pmc: PMC8948887
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Research, Development and Innovation Office
ID : FK131424
Organisme : European Union and the European Social Fund
ID : EFOP-3.6.3-VEKOP-16-2017-00009

Références

Therap Adv Gastroenterol. 2013 Jan;6(1):77-88
pubmed: 23320052
Lancet. 2005 Oct 1;366(9492):1197-209
pubmed: 16198769
Obesity (Silver Spring). 2021 Apr;29(4):645-653
pubmed: 33270351
Free Radic Biol Med. 2011 Nov 1;51(9):1621-35
pubmed: 21872656
J Transl Med. 2015 Apr 30;13:135
pubmed: 25925588
J Biol Chem. 2019 May 3;294(18):7296-7307
pubmed: 30877201
Horm Mol Biol Clin Investig. 2017 Sep 26;31(2):
pubmed: 28949928
Sci Transl Med. 2020 Aug 26;12(558):
pubmed: 32848096
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
Sci Rep. 2020 Jun 15;10(1):9632
pubmed: 32541826
Obesity (Silver Spring). 2017 Apr;25(4):704-712
pubmed: 28240819
Int J Mol Sci. 2019 Mar 06;20(5):
pubmed: 30845725
Sci Rep. 2019 Apr 9;9(1):5823
pubmed: 30967578
Nat Commun. 2021 Sep 1;12(1):5212
pubmed: 34471133
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8649-8654
pubmed: 28739898
Nat Rev Mol Cell Biol. 2021 Jun;22(6):393-409
pubmed: 33758402
Cell. 2020 Aug 6;182(3):563-577.e20
pubmed: 32615086
Mol Cell Endocrinol. 2015 Jul 5;409:21-32
pubmed: 25818883
Nat Rev Cardiol. 2018 Sep;15(9):543-554
pubmed: 30042431
Mol Aspects Med. 2020 Feb;71:100822
pubmed: 31587811
Int J Obes (Lond). 2014 Feb;38(2):170-6
pubmed: 23736373
FEBS J. 2015 Dec;282(24):4672-8
pubmed: 26432171
Sci Rep. 2015 Jul 27;5:12540
pubmed: 26212086
Cell Metab. 2013 May 7;17(5):798-805
pubmed: 23663743
J Clin Invest. 2015 Feb;125(2):478-86
pubmed: 25642708
Am J Physiol Regul Integr Comp Physiol. 2011 Aug;301(2):R285-96
pubmed: 21490370
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
J Mol Biol. 2020 Apr 3;432(8):2462-2482
pubmed: 31682838
Mol Cell Biol. 2004 Apr;24(7):3057-67
pubmed: 15024092
Sci Signal. 2018 Apr 24;11(527):
pubmed: 29692364
Sci Signal. 2017 Feb 28;10(468):
pubmed: 28246203
Cell Metab. 2013 Apr 2;17(4):491-506
pubmed: 23562075
Obes Facts. 2008;1(4):184-9
pubmed: 20054179
Nat Rev Dis Primers. 2017 Jun 15;3:17034
pubmed: 28617414
Science. 1999 Nov 12;286(5443):1368-71
pubmed: 10558993
Cell. 2005 Dec 16;123(6):993-9
pubmed: 16360030
Cell Metab. 2015 Oct 6;22(4):546-59
pubmed: 26445512
Cells. 2020 Dec 13;9(12):
pubmed: 33322168
Physiol Rev. 2004 Jan;84(1):277-359
pubmed: 14715917
Cell. 2010 Feb 5;140(3):313-26
pubmed: 20144757
Pharmaceuticals (Basel). 2021 May 06;14(5):
pubmed: 34066399
Cytometry A. 2013 Oct;83(10):933-43
pubmed: 23846866
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Mol Metab. 2018 Jan;7:35-44
pubmed: 29198749
Nat Rev Endocrinol. 2018 Jul;14(7):430-437
pubmed: 29799023
Nat Cell Biol. 2018 Sep;20(9):1013-1022
pubmed: 30154567
Int J Mol Sci. 2021 Oct 15;22(20):
pubmed: 34681787
Autophagy. 2015 Nov 2;11(11):2074-2088
pubmed: 26391754
Mol Cell Biol. 2008 Nov;28(22):6785-95
pubmed: 18794372
EMBO J. 2014 Mar 3;33(5):418-36
pubmed: 24431221
N Engl J Med. 2009 Apr 9;360(15):1500-8
pubmed: 19357405
FEBS Lett. 2010 Aug 4;584(15):3250-9
pubmed: 20600006
Trends Endocrinol Metab. 2018 Mar;29(3):191-200
pubmed: 29366777
Curr Cancer Drug Targets. 2019;19(6):468-478
pubmed: 30332964
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73
pubmed: 23725295
J Biol Chem. 2010 Mar 5;285(10):7153-64
pubmed: 20028987
Adipocyte. 2019 Dec;8(1):77-82
pubmed: 30686106
FEBS Lett. 2021 Aug;595(16):2085-2098
pubmed: 34197627
Pharmaceuticals (Basel). 2021 Oct 25;14(11):
pubmed: 34832860
J Clin Invest. 2013 Jan;123(1):469-78
pubmed: 23257354
J Clin Invest. 2013 Aug;123(8):3404-8
pubmed: 23867622
Redox Biol. 2019 Sep;26:101286
pubmed: 31382214
J Biol Chem. 2009 Sep 25;284(39):26385-93
pubmed: 19633298
Cell. 2012 Oct 12;151(2):400-13
pubmed: 23063128
Stem Cells. 2009 Nov;27(11):2753-60
pubmed: 19697348
Cell Metab. 2016 Sep 13;24(3):402-419
pubmed: 27568548
Trends Pharmacol Sci. 2004 Jun;25(6):331-6
pubmed: 15165749
Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15
pubmed: 11244452
Front Cell Dev Biol. 2021 Oct 11;9:737872
pubmed: 34708041
Int J Mol Sci. 2021 Aug 20;22(16):
pubmed: 34445679
Cell Metab. 2006 Mar;3(3):211-22
pubmed: 16517408
Endocr Rev. 2011 Aug;32(4):550-70
pubmed: 21642230
Diabetologia. 2016 Jun;59(6):1075-88
pubmed: 27039901
Stem Cells Transl Med. 2017 Apr;6(4):1096-1108
pubmed: 28186685
Nat Rev Endocrinol. 2018 Jun;14(6):331-344
pubmed: 29654249
Int J Mol Sci. 2020 Sep 10;21(18):
pubmed: 32927882
Nat Commun. 2021 May 17;12(1):2876
pubmed: 34001883
Int J Mol Sci. 2017 Aug 28;18(9):
pubmed: 28846632
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Nature. 2015 Aug 20;524(7565):309-314
pubmed: 26266977
J Lipid Res. 2019 Oct;60(10):1648-1684
pubmed: 31209153
Autophagy. 2013 Nov 1;9(11):1653-62
pubmed: 24121704
Nat Rev Mol Cell Biol. 2013 Dec;14(12):759-74
pubmed: 24201109
Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E601-6
pubmed: 20606075
Cell Mol Life Sci. 2016 Feb;73(4):775-95
pubmed: 26611876
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17970-17979
pubmed: 31420514
Nat Med. 2016 Mar;22(3):312-8
pubmed: 26808348
Int J Mol Sci. 2021 Apr 09;22(8):
pubmed: 33918863
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
Cell. 2014 Jan 16;156(1-2):20-44
pubmed: 24439368
N Engl J Med. 2009 Apr 9;360(15):1518-25
pubmed: 19357407

Auteurs

Attila Vámos (A)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, H-4032 Debrecen, Hungary.

Abhirup Shaw (A)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, H-4032 Debrecen, Hungary.

Klára Varga (K)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, H-4032 Debrecen, Hungary.

István Csomós (I)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Gábor Mocsár (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Zoltán Balajthy (Z)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Cecília Lányi (C)

Laser Clinic, H-1012 Budapest, Hungary.

Zsolt Bacso (Z)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
Faculty of Pharmacy, University of Debrecen, H-4032 Debrecen, Hungary.

Mária Szatmári-Tóth (M)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Endre Kristóf (E)

Laboratory of Cell Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Classifications MeSH